A novel cuproptosis-related lncRNAs signature predicts prognosis in bladder cancer

This study constructed a novel cuproptosis-related lncRNAs signature to predict the prognosis of BLCA patients. The Cancer Genome Atlas (TCGA) database was used to retrieve the RNA-seq data together with the relevant clinical information. The cuproptosis-related genes were first discovered. The cuproptosis-related lncRNAs were then acquired by univariate, the least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analysis to create a predictive signature. An eight cuproptosis-related lncRNAs (AC005261.1, AC008074.2, AC021321.1, AL024508.2, AL354919.2, ARHGAP5-AS1, LINC01106, LINC02446) predictive signature was created. Compared with the low-risk group, the prognosis was poorer for the high-risk group. The signature served as an independent overall survival (OS) predictor. Receiver operating characteristic (ROC) curve indicated that the signature demonstrated superior predictive ability, as evidenced by the area under the curve (AUC) of 0.782 than the clinicopathological variables. When we performed a subgroup analysis of the different variables, the high-risk group’s OS for BLCA patients was lower than that of the low-risk group’s patients. Gene Set Enrichment Analysis (GSEA) showed that high-risk groups were clearly enriched in many immune-related biological processes and tumor-related signaling pathways. Single sample gene set enrichment analysis (ssGSEA) revealed that the immune infiltration level was different between the two groups. Finally, quantitative RT-PCR showed that AC005261.1, AC021321.1, AL024508.2, LINC02446 and LINC01106 were lowly expressed in tumor cells, while ARHGAP5-AS1 showed the opposite trend. In summary, the predictive signature can independently predict the prognosis and provide clinical treatment guidance for BLCA patients.

[1]  Tianyue Wang,et al.  Identification and integration analysis of a novel prognostic signature associated with cuproptosis-related ferroptosis genes and relevant lncRNA regulatory axis in lung adenocarcinoma , 2023, Aging.

[2]  Zhongyuan Chen,et al.  A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation , 2022, Medicine.

[3]  B. Liu,et al.  Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma , 2022, Frontiers in Pharmacology.

[4]  Zhiyuan Chen,et al.  Accurate Diagnosis and Survival Prediction of Bladder Cancer Using Deep Learning on Histological Slides , 2022, Cancers.

[5]  Chao Tu,et al.  Identification of cuproptosis-related lncRNA prognostic signature for osteosarcoma , 2022, Frontiers in Endocrinology.

[6]  Lili Li,et al.  A Novel Risk Model for lncRNAs Associated with Oxidative Stress Predicts Prognosis of Bladder Cancer , 2022, Journal of oncology.

[7]  Jinwu Peng,et al.  Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers , 2022, Frontiers in Oncology.

[8]  Ke Xu,et al.  A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA , 2022, Frontiers in Immunology.

[9]  R. Zhai,et al.  PM2.5 promotes NSCLC carcinogenesis through translationally and transcriptionally activating DLAT-mediated glycolysis reprograming , 2022, Journal of experimental & clinical cancer research : CR.

[10]  Xianwei Zhang,et al.  A novel Cuproptosis-related LncRNA signature to predict prognosis in hepatocellular carcinoma , 2022, Scientific Reports.

[11]  Yongqiang Wang,et al.  Cuproptosis: a new form of programmed cell death , 2022, Cellular & Molecular Immunology.

[12]  T. Golub,et al.  Copper induces cell death by targeting lipoylated TCA cycle proteins , 2022, Science.

[13]  Hui Cao,et al.  A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients , 2021, Frontiers in Cell and Developmental Biology.

[14]  A. Casini,et al.  Connecting copper and cancer: from transition metal signalling to metalloplasia , 2021, Nature Reviews Cancer.

[15]  Yanmin Li,et al.  Associations between inflammasome‐related gene NLRP3 Polymorphisms (rs10754558 and rs35829419) and risk of bladder cancer in a Chinese population , 2021, Journal of clinical laboratory analysis.

[16]  Changzhu Duan,et al.  FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma , 2021, Frontiers in Pharmacology.

[17]  G. Long,et al.  Immune checkpoint inhibitors in melanoma , 2021, The Lancet.

[18]  Yumeng Chai,et al.  Identification of a Nomogram from Ferroptosis-Related Long Noncoding RNAs Signature to Analyze Overall Survival in Patients with Bladder Cancer , 2021, Journal of oncology.

[19]  Hui Cao,et al.  The molecular feature of macrophages in tumor immune microenvironment of glioma patients , 2021, Computational and structural biotechnology journal.

[20]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[21]  Xi Liu,et al.  Long non-coding RNA LINC02446 suppresses the proliferation and metastasis of bladder cancer cells by binding with EIF3G and regulating the mTOR signalling pathway , 2021, Cancer Gene Therapy.

[22]  Hao Wu,et al.  Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature , 2021, Bioengineered.

[23]  Hang Tong,et al.  An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer , 2020, Bioscience reports.

[24]  Zhaoxu Liu,et al.  LINC01106 post-transcriptionally regulates ELK3 and HOXD8 to promote bladder cancer progression , 2020, Cell Death & Disease.

[25]  Yonghua Wang,et al.  Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer. , 2020, International immunopharmacology.

[26]  M. Petris,et al.  Copper metabolism as a unique vulnerability in cancer. , 2020, Biochimica et biophysica acta. Molecular cell research.

[27]  A. Kamat,et al.  Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. , 2020, European urology oncology.

[28]  Lei Wang,et al.  Inhibition of BRD4 prevents proliferation and epithelial–mesenchymal transition in renal cell carcinoma via NLRP3 inflammasome-induced pyroptosis , 2020, Cell Death & Disease.

[29]  F. Feng,et al.  Integrated analysis of co‐expression and ceRNA network identifies five lncRNAs as prognostic markers for breast cancer , 2019, Journal of cellular and molecular medicine.

[30]  Y. Liu,et al.  LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint , 2019, Cell Death & Disease.

[31]  P. Ji,et al.  Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils , 2019, Journal of Experimental & Clinical Cancer Research.

[32]  Yan Wang,et al.  Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability. , 2019, American journal of translational research.

[33]  Lei Li,et al.  Long non‐coding RNA LINC01535 promotes cervical cancer progression via targeting the miR‐214/EZH2 feedback loop , 2019, Journal of cellular and molecular medicine.

[34]  Hongchuan Jin,et al.  Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer , 2019, Cell Death & Disease.

[35]  Q. Cao,et al.  LXRα promotes cell metastasis by regulating the NLRP3 inflammasome in renal cell carcinoma , 2019, Cell Death & Disease.

[36]  Yicheng Zhao,et al.  Blockage of SLC31A1‐dependent copper absorption increases pancreatic cancer cell autophagy to resist cell death , 2019, Cell proliferation.

[37]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[38]  Mark Gerstein,et al.  GENCODE reference annotation for the human and mouse genomes , 2018, Nucleic Acids Res..

[39]  Dong Eun Kim,et al.  A novel anti‐cancer agent, FPDHP, induces anoikis in various human cancer cells through activation of calpain, and downregulation of anoikis‐related molecules , 2018, Journal of cellular biochemistry.

[40]  J. Hansson,et al.  Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness , 2018, Cancer Immunology Research.

[41]  B. Dai,et al.  Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer , 2018, Oncoimmunology.

[42]  J. Mendell,et al.  Functional Classification and Experimental Dissection of Long Noncoding RNAs , 2018, Cell.

[43]  Chris Berdik.  Unlocking bladder cancer , 2017, Nature.

[44]  Maximilian Burger,et al.  EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.

[45]  O. Stål,et al.  Defining the human copper proteome and analysis of its expression variation in cancers. , 2017, Metallomics : integrated biometal science.

[46]  K. Tomczak,et al.  The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge , 2015, Contemporary oncology.

[47]  A. Masson-Lecomte,et al.  Conditional survival after radical cystectomy for bladder cancer: evidence for a patient changing risk profile over time. , 2014, European urology.

[48]  D. Hanahan,et al.  Bioavailable copper modulates oxidative phosphorylation and growth of tumors , 2013, Proceedings of the National Academy of Sciences.

[49]  D. Thiele,et al.  Mechanisms for copper acquisition, distribution and regulation. , 2008, Nature chemical biology.

[50]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Shannon,et al.  Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks , 2003 .

[52]  C. Pashos,et al.  The health economics of bladder cancer , 2012, PharmacoEconomics.